Global Ophthalmic Drugs Market Size By Type (Prescription Drugs, OTC Drugs), By Disease (Dry Eye, Glaucoma), By Dosage (Gels, Eye Solutions & Suspensions), By Distribution Channel (Hospital Pharmacies, Drug Stores), By Geographic Scope And Forecast

Ophthalmic Drugs Market Size And Forecast

Ophthalmic Drugs Market size was valued at USD 34.09 Billion in 2022 and is projected to reach USD 70.22 Billion by 2030, growing at a CAGR of 8.2% from 2023 to 2030.

Rapidly flourishing pharmaceutical industry along with the increasing prevalence of chronic illness and aging population is anticipated to drive market growth over the forecast period. The Global Ophthalmic Drugs Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Ophthalmic Drugs Market Definition

Ophthalmic drugs are generally used to treat eye-related diseases such as conjunctivitis, ocular blepharitis, keratitis, and others. Ophthalmic drugs are available in various drug classes including macrolides, aminoglycosides, quinolones, sulfonamides, and polypeptides. These drugs can also be used in combination with other antibiotics or corticosteroids. The rising prevalence of eye diseases has generated and augmented the need for ophthalmic drugs.

Nearly 2.2 billion people are affected globally by ophthalmic conditions such as AMD (170 million), cataracts (94 million), glaucoma (7.7 million), and diabetic retinopathy (DR) (3.9 million). Drugs used to treat these conditions are therefore required to effectively reach the target area of the eye, resulting in different delivery requirements.

Drug delivery to the eye is categorized as anterior and posterior segments. Conventional delivery systems including suspensions, ointments, and drops are not optimal in the treatment of ophthalmic diseases. However, nearly 90% of the ophthalmic formulations marketed currently are in the form of eye drops which mainly target diseases in the anterior segment of the eye. The posterior segment (retina, vitreous, choroid) can be effectively treated by intravenously or by intravitreal administration, using a high drug dosage regimen. Currently, the posterior segment drug delivery is showing promising growth in ophthalmic drug delivery.

Global Ophthalmic Drugs Market Overview

When it comes to getting medication into the eye, delivering drugs to the front of the eye is way more common than targeting the back. You probably already know the go-to treatments for this – eye drops and ointments – they're super easy to use! But, even though they're popular, they've got some issues. It's tough to get them to really soak into the cornea, and it's hard to make their effects last long enough to actually work. Some studies even say that only about 5-10% of the eye drop medicine actually does its job, which isn't great. Why? Well, your eye can only hold so much fluid, so a lot of the drop just spills out. Plus, blinking and natural drainage kick in, washing the medicine away before your eye can absorb it.

Posterior eye drugs requiring delivery when compared to that anterior ones are even more challenging. They are required to exactly reach the retina for which injections or implants are often used. Implantable drug delivery owing to sustained release potential is currently a subject of greater interest among organizations. Furthermore, these implantable drugs can either be bio durable or bioresorbable (absorbed by the body over time).  Implantable manufacturing processes include injection molding, hot-melt extrusion, and solvent-based methods. However, not all implantable are well-suited for these methods, and determining a suitable method requires a systematic understanding of these manufacturing procedures.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Ophthalmic Drugs Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. The porter’s five forces model can be used to assess the competitive landscape in global Ophthalmic Drugs Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Global Ophthalmic Drugs Market Segmentation Analysis

The Global Ophthalmic Drugs Market is Segmented on the basis of Type, Disease, Dosage, Distribution Channel, And, Geography.

Ophthalmic Drugs Market, By Type

• Prescription Drugs
• OTC Drugs

On the basis of Type, The Global Ophthalmic Drugs Market is segmented into prescription drugs and OTC Drugs. Prescription drugs accounted for largest market share in 2022 and is expected to follow the trend over the period. Rising prevalence of diseases such as eye infections, diabetes and cataract among others is anticipated to drive the market demand over the forecast period. Prescription products exhibit higher effectiveness for treating ophthalmic disorders and are generally preferred over OTC products.

Ophthalmic Drugs Market, By Disease

• Dry Eye
• Glaucoma
• Infection/Inflammation/Allergy
• Retinal Disorders
• Others

On the basis of Disease, The Global Ophthalmic Drugs Market is segmented into Dry Eye, Glaucoma, Infection/Inflammation/Allergy, Retinal Disorders, and Others. The retinal disorder segment accounted for the largest market share in 2022.  The segment growth can be attributed to the rising occurrence of diabetic retinopathy and macular degeneration. Furthermore, glaucoma accounted for the second-largest market in 2022. Glaucoma occurs due to the buildup of fluid in the front eye, thus damaging the optic nerve.

Ophthalmic Drugs Market, By Dosage

• Gels
• Eye Solutions & Suspensions
• Capsules and Tablets
• Others

On the basis of Dosage, the Global Ophthalmic Drugs Market is segmented into gels, eye solutions & suspensions, capsules & tablets, and others. Eye solutions & suspensions accounted for the largest market share in 2022. The segment growth can be attributed to ease of application of products along with the rising demand for OTC drugs. Ophthalmic gels are most commonly used for treating dry and irritated eyes which occur due to excessive exposure to the sun, wind, heating/air conditioning, screen time, as well as some medications

Ophthalmic Drugs Market, By Distribution Channel

• Hospital Pharmacies
• Drug Stores
• Online Pharmacies
• Others

On the basis of Distribution Channel, the Global Ophthalmic Drugs Market is segmented into hospital pharmacies, drug stores, online pharmacies, and others. Hospital pharmacies accounted for the largest market share in 2022. The online pharmacies segment is expected to witness the highest CAGR owing to growing consumer inclination towards digital mediums, as well as the ease of product purchase offered by the medium.

Ophthalmic Drugs Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Looking at the world, the ophthalmic drugs market is divided up by regionNorth America, Europe, Asia Pacific, and the rest of the world. Turns out, North America grabs the biggest chunk of the revenue pie, thanks to its seriously advanced pharmaceutical and medical industries. And within North America, the U.S. is the heavyweight champ, both in the region and globally! They're always pumping money into discovering and creating cutting-edge treatments. Now, keep an eye on Asia Pacific! Experts think it's going to grow fast, mainly because there are lots of older folks there, plus a rising number of people dealing with chronic conditions like diabetes and cataracts.

Key Players

The “Global Ophthalmic Drugs Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Aerie Pharmaceuticals Inc, AbbVie, Bayer AG, Bausch Health Companies Inc, and Novartis AG, F. Hoffmann-La Roche Ltd, Viatris Inc, Regeneron Pharmaceuticals Inc, Santen Pharmaceutical Co. Ltd, Alcon, among others.

These players exhibit high production capacities, strong market foothold and distribution network and are investing heavily in research and development activities in order to upscale their technologies and enhance product features which are application specific.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

We'll take a good hard look at the market, breaking it down into different groups based on things like income, but also other stuff that's not just about money. You'll see the market size in USD Billion for each of those groups and smaller subgroups. We'll point out which region and group we think will grow the quickest and be the biggest. Plus, we'll analyze each region geographically, looking at how much of the product or service they're using and what's influencing the market there. Think of it as a competitive arena, where we rank the big players and highlight what they've been up to in the last five years – new products, partnerships, expansions, and acquisitions. We'll also give you detailed company profiles, with overviews, insights, product comparisons, and SWOT analyses. You'll get our view on where the market is now and where it's headed, based on the latest trends, opportunities, and the challenges popping up in both new and established markets. We'll even use Porter's five forces to really dig into the market from all angles and provide some value chain insights. Expect a market dynamics scenario with growth opportunities for the coming years. Oh, and don't forget the 6-month post-sales analyst support.

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.